Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples, and freeze-thaw system of biological stock solution; and single use technology, such as bioreactor, liquid distribution system, sterile bag, process chromatography, membrane filtration system, and others. It also provides culture medium, such as cell and gene therapy, biomacromolecule drugs, tobitec feeding medium, and other series; bioreactor and fermentation systems, cell factory, perfusion, and complementary systems; preparation systems, such as bio-process vessel and piping, common solutions, and complex injectable formulation systems; and separation and purification systems, including disc centrifuge membrane filtration, chromatography system and columns, alkali lysis, slurry tank, and filters. In addition, the company offers freeze-drying system, including laboratory, production, and special application freeze-drying products, as well as loading and unloading system; and packaging systems, such as packaging solutions, cartoner machine, top-load cartoner machines, bilster machine, solid bottling equipment, labelling machine, and case packer with palletizer machines. Further, it provides resins, API, isolator system, cleaning and sterilization, filling line, and inspection system products; and engineering services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. Tofflon Science and Technology Group Co., Ltd. was founded in 1993 and is headquartered in Shanghai, China.